Researchers from the La Jolla Institute for Allergy & Immunology (LIAI) announced today the results of a first of its kind study analyzing all published data worldwide on influenza A virus antibody and T cell epitopes.
Antibody and T cell epitopes are small sites on a virus that are the targets of the immune response, and they are critical for developing therapies and vaccines to combat infectious disease. The study, using information from a worldwide research database funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), provides an important tool for scientists seeking to develop vaccines and therapies against both seasonal and pandemic influenza strains, including the deadly H5N1 avian flu.
"This study shows what is currently known about influenza A virus epitopes -- what are the areas that are well covered in the current research and where are the holes in our knowledge," said Alessandro Sette, Ph.D., director of LIAI's Center for Infectious Disease and one of the study's authors. "From this information, the scientific community can determine areas where focus is needed going forward."
The findings are being published online this week in a paper, "Antibody and T Cell Epitopes of Influenza A Virus – Knowledge and Opportunities" in the journal Proceedings of the National Academy of Sciences USA. LIAI researcher Huynh-Hoa Bui, Ph.D., was lead author on the paper.
The study looked at all scientific data on influenza A virus antibody and T cell epitopes published to date worldwide, drawing from the NIAID's Immune Epitope Database, a new worldwide scientific resource that went public last summer. LIAI researchers developed the database – which is the world's largest repository of scientific data on how the body's immune system responds to infectious agents -- under a $25 million contract awarded by the NIAID in 2004.
The database places particular emphasis on emerging infectious diseases, such as West Nile virus, along with those diseases considered potential bioterrorist threats. The database's influenza research was analyzed first due to the continuing problem of seasonal influenza and public health concerns over the possible spread of the H5N1 avian flu.
"The database marks the first time that all known antibody and T cell epitope information has been compiled in one place," said Sette, noting the searchable online database is freely available to scientists around the globe. "It gives researchers ways of sharing knowledge and information never available before. Previously, everyone did their own study, but would have no way of knowing if a particular epitope had been used one time, for example by a single individual responding to a single virus, or 100 different times. Now, scientists can search the database and find out all existing information on their particular topic. This will enable them to avoid unnecessary repetition and make faster progress toward new therapies and vaccines."
The database, publicly accessible at http://immuneEPITOPE.org, includes information culled from more than 100,000 separate research articles published over several decades, with the influenza information representing only a portion of the massive data set. "The influenza data shows that people have done a lot of work that gives important information as to how we respond to influenza virus," said Stephen Wilson, Ph.D., LIAI chief technology officer and project director of the database. "It also highlights those critical areas where we need to look further. The fact that we don't have a comprehensive vaccine for flu shows we have more work to do. This study shows us where we need to focus going forward."
For the influenza study, LIAI researchers analyzed information from 58 different influenza A virus strains, involving 600 different antibody and T cell epitopes. In particular, the LIAI scientists identified epitopes that were similar in many influenza strains. "This is important because the influenza virus continually changes requiring scientists to develop a new vaccine every year," Sette said. "If we can find shared epitopes, it may be possible to develop an influenza vaccine with greater cross protection for many different viruses." Sette said the study found hundreds of similar epitopes among the different virus strains. However, it remains to be seen whether these epitopes are similar enough to enable the successful development of a highly cross reactive influenza vaccine that would protect against many viruses. And, in fact, the study found only one epitope that has been published, which appears to be an ideal candidate for creating a multi-strain influenza vaccine.
Regarding gaps in knowledge of the way people respond to influenza, Wilson said two significant points emerged. "One concern is that most of the current influenza research is based on strains maintained in the lab, rather than wild influenza strains. Since we know the virus mutates, research needs to be done using influenza strains currently circulating in the population, so-called 'wild' strains, rather than using strains propagated in the lab. "
Secondly, Wilson noted that the analysis showed that most of the detailed studies were done in animal models, primarily mice, with very little data coming from studies with humans or birds. Only one of the antibody epitopes came from a human. "This is understandable given the ethical and health issues of testing a potential pathogen in humans," Wilson said. "However, based on this information, I think the research community will pursue data directly relevant to human immunity to influenza virus to close those critical gaps."
Regarding the dreaded H5N1 avian flu specifically, the information showed some important H5N1 epitopes currently being investigated. However, the number represented only a few of the 600 influenza virus epitopes in the database. "Given the concerns among the worldwide health community about this virus, I think this data gives timely assistance to much needed research in this area," Wilson said. He noted that such information is extremely valuable and shows how important the database can be for all researchers in determining their future research plans. "This study focused on influenza because it is a major illness that kills 36,000 Americans each year and global concerns over the possible spread of the H5N1 avian flu. In the future, database information on other infectious diseases can also be analyzed and used to good effect."
Bonnie Ward | EurekAlert!
Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz
Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB
More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.
Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...
Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.
"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...
The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.
Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...
The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...
Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.
Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...
28.04.2017 | Event News
20.04.2017 | Event News
18.04.2017 | Event News
28.04.2017 | Medical Engineering
28.04.2017 | Earth Sciences
28.04.2017 | Life Sciences